A subsequent comprehensive literature review of 181 families with GPV in BAP1 by Walpole et al. [2] assessed cancers associated with BAP1 GPV and suggested that mesothelioma (peritoneal and pleural), uveal melanoma, cutaneous melanoma, and renal carcinoma are core cancers in the phenotype, occurring in 24.5%, 36.2%, 23.4%, and 5.7% of 141 proband carriers and 16.9%, 15.9%, 12.0%, and 4.9% of 183 non-proband carriers respectively. The gene discussed is BAP1; the disease is cutaneous melanoma.